Table 3.
FES (n = 94) | Control (n = 96) | p-Value | |
---|---|---|---|
Any adverse event | 7 (7) | 2 (2) | 0.10 |
Adverse events related to treatment | 0 | 0 | - |
Any serious adverse event | 1 (1) | 0 | 0.49 |
FES (n = 94) | Control (n = 96) | p-Value | |
---|---|---|---|
Any adverse event | 7 (7) | 2 (2) | 0.10 |
Adverse events related to treatment | 0 | 0 | - |
Any serious adverse event | 1 (1) | 0 | 0.49 |